Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.2K Buy
+612
New +$40.8K 0.01% 556
2025
Q4
Sell
-3
Closed -$199 1105
2025
Q3
$199 Buy
+3
New +$237 ﹤0.01% 1077
2025
Q2
Sell
-27
Closed -$1.84K 1108
2025
Q1
$1.84K Sell
27
-174
-87% -$14.2K ﹤0.01% 980
2024
Q4
$15.6K Buy
201
+197
+4,925% +$14.6K ﹤0.01% 863
2024
Q3
$269 Buy
+4
New +$328 ﹤0.01% 1097

Other funds holding DXCM

Colonial Trust's DXCM Position: Q2 2026 in Review

Colonial Trust opened a new position in DexCom (DXCM) in Q2 2026: 612 shares worth $41.2K. The stake represents 0.01% of the portfolio and ranks #556 among its holdings. This is a return to the name: Colonial Trust previously reported a position in DXCM as recently as Q3 2025.

Colonial Trust first reported a position in DXCM in Q3 2024 and has held it in 5 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Colonial Trust held 612 shares of DexCom worth $41.2K as of Q2 2026.
  • DexCom was a new Colonial Trust position in Q2 2026.
  • DexCom made up 0.01% of Colonial Trust's portfolio in Q2 2026, its #556 holding.
  • Colonial Trust first reported a position in DexCom in Q3 2024 and has held it in 5 quarters since.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.